Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Not Applicable

Recruiting

Conditions: Locally Advanced Breast Cancer
Breast Cancer

Interventions: Procedure: Sentinel Lymph Node Biopsy (SLNB)

First Posted Date: 2017-08-21

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT03255577

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only and Follow Up), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 5 locations

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Recruiting

Conditions: Lymphedema

Interventions: Behavioral: Quality of Life Assessments

First Posted Date: 2017-08-14

Last Posted Date: 2025-05-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 600

Registration Number: NCT03248310

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Phase 1

Active, not recruiting

Conditions: High Grade Serous Ovarian
Fallopian Tube
Primary Peritoneal Cancer

Interventions: Drug: Carboplatin and Paclitaxel
Drug: Nivolumab
Procedure: Cytoreductive surgery
Drug: Ipilimumab

First Posted Date: 2017-08-10

Last Posted Date: 2025-04-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT03245892

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Phase 1

Active, not recruiting

Conditions: Pancreatic Adenocarcinoma

Interventions: Drug: Durvalumab
Radiation: Stereotactic Ablative Body Radiotherapy (SABR)

First Posted Date: 2017-08-10

Last Posted Date: 2024-10-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03245541

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

and more 4 locations

A Study of Nivolumab in Selected Uterine Cancer Patients

Phase 2

Completed

Conditions: Uterine Cancer
Clear Cell Carcinoma
Endometrial Carcinoma
Carcinosarcoma
Leiomyosarcoma
Undifferentiated Sarcoma
High Grade Endometrial Stromal Sarcoma

Interventions: Drug: Nivolumab

First Posted Date: 2017-08-07

Last Posted Date: 2024-12-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT03241745

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 5 locations

Pembrolizumab (immunotherapy Drug) in Combination with Guadecitabine and Mocetinostat (epigenetic Drugs) for Patients with Advanced Lung Cancer.

Phase 1

Active, not recruiting

Conditions: Lung Cancer

Interventions: Drug: Pembrolizumab
Drug: Guadecitabine
Drug: Mocetinostat

First Posted Date: 2017-07-18

Last Posted Date: 2024-12-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT03220477

Locations: 🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2

Active, not recruiting

Conditions: Brain Tumor

Interventions: Drug: abemaciclib

First Posted Date: 2017-07-18

Last Posted Date: 2024-07-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT03220646

Locations: 🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only), Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 5 locations

Proton Re-Irradiation for Recurrent Head and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: hypofractionated palliative re-irradiation
Radiation: conventionally fractionated full dose re-irradiation

First Posted Date: 2017-07-14

Last Posted Date: 2024-12-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 87

Registration Number: NCT03217188

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Baptist Alliance MCI, Miami, Florida, United States

and more 6 locations

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Early Phase 1

Active, not recruiting

Conditions: Thyroid Cancer

Interventions: Drug: Durvalumab (Medi4736)
Radiation: Radioiodine (RAI)

First Posted Date: 2017-07-12

Last Posted Date: 2024-07-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT03215095

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

Not Applicable

Active, not recruiting

Conditions: Parents

Interventions: Behavioral: HPV Vaccine Education
Behavioral: Text Messaging Reminder

First Posted Date: 2017-07-06

Last Posted Date: 2025-04-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 672

Registration Number: NCT03209713

Locations: 🇺🇸
Research, Education and Access to Community Health (REACH), Las Vegas, Nevada, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
The University of Texas at El Paso, El Paso, Texas, United States

and more 1 locations

AI-Powered Research

Premium Access

Memorial Sloan Kettering Cancer Center

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

A Study of Nivolumab in Selected Uterine Cancer Patients

Pembrolizumab (immunotherapy Drug) in Combination with Guadecitabine and Mocetinostat (epigenetic Drugs) for Patients with Advanced Lung Cancer.

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Proton Re-Irradiation for Recurrent Head and Neck Cancer

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination